skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Virulizin (Code C26677)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Virulizin

Definition: A natural biological response modifier (BRM) isolated from bovine reticuloendothelial tissue. Viruzlin may enhance cell-mediated immune response to tumor cells by direct macrophage activation. (NCI04)

NCI-GLOSS Definition: A substance that activates some types of immune system cells, and is being studied as a treatment for cancer. It belongs to the family of drugs called biological therapy agents.

Label: Virulizin

NCI Thesaurus Code: C26677 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0254455  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Virulizin

External Source Codes: 
CAS Registry Number 216586-46-8 (see NLM ChemIDplus info)
PDQ Closed Trial Search ID 257159
PDQ Open Trial Search ID 257159 (check for NCI PDQ open clinical trial info)
UMLS CUI C0254455

Other Properties:
     Name Value (qualifiers indented underneath)
code C26677
Legacy_Concept_Name Virulizin
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  

URL: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C26677

Mainbox Bottom